TG Therapeutics to price public offering of stock overnight July 17

Roth, Ladenburg Thalmann and Brean Capital are the bookrunners

By Aleesia Forni and Devika Patel

Virginia Beach, Va., July 17 - TG Therapeutics, Inc. will price a public sale of common shares overnight on July 17, according to an informed source.

Roth Capital Partners LLC, Ladenburg Thalmann & Co. Inc. and Brean Capital LLC are the joint bookrunning managers. National Securities Corp. is the co-manager.

The sale has a 30-day greenshoe that could expand the offering size by 15%.

The biopharmaceutical company is based in New York.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.